![Vertex Pharmaceuticals Stock Quote](https://g.foolcdn.com/art/companylogos/mark/VRTX.png)
Vertex Pharmaceuticals (NASDAQ: VRTX)
Vertex Pharmaceuticals Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
3 No-Brainer Stocks to Buy in September
There's at least one key common denominator here: tremendous growth prospects.
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Vertex should have a future full of bright tomorrows.
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
Vertex Pharmaceuticals has a lot going for it.
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
It's always a good time to invest cash in quality businesses.
2 Biotech Stocks to Buy Hand Over Fist in August
Both of these biotechs are highly innovative companies.
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Shares of the rare disease drugmaker are already up more than 40% over the past year.
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
Great companies are found in every type of market landscape.
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
These two healthcare companies have far more upside potential than Johnson & Johnson.
Valuation
Podcast Episodes
![MFM_20230615](https://g.foolcdn.com/editorial/images/736757/mfm_20230615.jpg?width=160)
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
![cover_IF](https://g.foolcdn.com/editorial/images/556636/cover_if.jpg?width=160)
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
![20191120 If Healthcare_thumbnail](https://g.foolcdn.com/editorial/images/548677/20191120-if-healthcare_thumbnail.png?width=160)
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2024.
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2024.
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2023.
Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.